论文部分内容阅读
广泛用于急性髓性白血病有三种治疗方法:异基因骨髓移植、自体骨髓移植及化疗。分析及比较此三种治疗的结果是复杂的和有争议的。比较已发表的结果问题在于报告的偏见及病例的选择。随机的试验也有报告,但其病例数目过少,其结论能否应用于多数急性髓性白血病(AML)是有问题的。随机试验研究的设计常常是被误解的或只是AML中的一部分人,在许多试验中相当大的一部分人未接受足够的治疗。观察的资料也常是不同AML的治疗结果的比
Widely used in acute myeloid leukemia there are three treatment methods: allogeneic bone marrow transplantation, autologous bone marrow transplantation and chemotherapy. Analyzing and comparing the results of these three treatments is complex and controversial. The problem with comparing published results is the reported bias and the choice of case. Randomized trials have also been reported, but the number of cases is too small, and its conclusion can be problematic for the majority of acute myeloid leukemia (AML). The design of randomized trial studies is often misunderstood or is only a subset of people in AML, and in many trials a significant proportion of people did not receive adequate treatment. The observed data is also often the ratio of treatment outcomes for different AMLs